Ardelyx (ARDX) Competitor Comparison
We are evaluating the key criteria listed to compare Ardelyx (ARDX) against its competitors in the Biotechnology industry.
Market Capitalization
76 / 368Gross Profits
91 / 278Total Revenue
80 / 300EBITDA
68 / 337Free Cashflow
175 / 352Quick Ratio
191 / 357Earnings per Share
68 / 359Dividend yield
0 / 6Total Cash
179 / 358Performance 3 years
17 / 368Performance 5 years
162 / 368Performance 10 years
195 / 368Linearity 3 years
331 / 368Linearity 5 years
106 / 368Linearity 10 years
216 / 367Total Rank
166 / 368Dividend Rank
360 / 368Valuation Rank
184 / 368Piotroski Rank
87 / 368Muliplier Rank
277 / 368Market Capitalization - ARDX ranking 76 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.